Name

Shaily Engineering Plastics

Legal name

Shaily Engineering Plastics Ltd.

Website

https://shaily.com

Company type

Public

Founded year

1987

Operating status

Operating

Headcount range

501–1,000 employees

Ownership category

akta.pro rank

Product category

Precision Plastic Contract Manufacturing

NAICS

Plastics Product Manufacturing (3261), Plastics and Rubber Products Manufacturing (326)

SIC

Miscellaneous Plastics Products (3080)

akta.pro primary industry

High-Performance & Engineering Polymers Injection Molding (PEEK, PPS, LCP, etc.) (IMANAFAK)

akta.pro secondary industry

Automotive & Transportation Injection Molded Parts (IMANAFAB)

Keywords

• Precision injection molding
• Drug delivery devices
• Contract manufacturing services
• Pen injector platforms
• Plastic component manufacturing

Headquarters

HQ city

Vadodara

HQ country

India

HQ region

Asia

Offices9 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Revenue model

1. Contract Manufacturing - Healthcare: CDMO services for pharmaceutical companies including design, development, and manufacturing of drug delivery devices (pen injectors, auto-injectors) and primary packaging. Revenue from long-term supply agreements with pharma companies. Healthcare segment grew 139% to ₹393 crores in FY26.
2. Contract Manufacturing - Consumer & Industrial: Precision plastic components manufacturing for consumer goods, beauty/personal care, lighting, appliances, and automotive sectors. Serves Fortune 100 companies including IKEA, P&G, HUL with components for homeware, cosmetics packaging, and industrial applications.
3. Sheet Steel Furniture: Sheet metal furniture manufacturing with 70,000 sq ft plant processing 6,000 tons of steel per annum, producing cabinets, drawer units, tables and storage units for global customers.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels4 records

Core offering

Shaily Engineering Plastics is a precision plastic components manufacturer and CDMO offering end-to-end solutions from concept to commercialization. The company operates 210 injection molding machines (35-1200 tons) across seven manufacturing plants, producing proprietary pen injector and auto-injector drug delivery platforms (ShailyPen, Shaily AI), primary pharmaceutical packaging, and precision plastic components for consumer goods, beauty/personal care, lighting, appliances, and automotive sectors.

Product overview

Shaily Engineering Plastics is a precision plastic components manufacturer offering a diversified portfolio across four main verticals: Healthcare (drug delivery devices and primary packaging), Consumer products (homeware and sheet steel furniture), Beauty and Personal Care (cosmetics packaging and personal care products), and Lighting, Appliances and Automotive. Within Healthcare, the company operates as both a CDMO for global pharmaceutical companies and a platform devices provider with its proprietary pen injector and auto-injector product lines (ShailyPen and Shaily AI series), plus primary and specialty pharmaceutical packaging. The product architecture follows a platform-plus-modules model where core device platforms (pen injectors, auto-injectors, wearable devices) are customized for specific drug therapies and delivered as both contract manufacturing services and proprietary platforms.

Differentiator

Problem solved

Functional benefit

Brands

• ShailyPen: Platform of pen injectors including ShailyPen Axiom, ShailyPen Protean, ShailyPen Neo, ShailyPen Axiom Max, ShailyPen Harmony 2, and ShailyPen Maxim for insulin and GLP-1 drug delivery.
• Shaily AI
• Shaily Mira
• ShailySafe LAN
• Shaily Innovations

Products and services

• ShailyPen Axiom Fixed-dose pen injector for teriparatide, PTH, and FSH therapies featuring a zero-prime design with red line indication when dose is selected and audible clicking during dose delivery.
• ShailyPen Protean Disposable or reusable pen injector for insulin (0-60 units), liraglutide, abaloparatide, and semaglutide; available in multiple configurations with high gearing and low force injection.
• ShailyPen Neo Variable or fixed-dose spring-driven pen injector for GLP-1, liraglutide, and semaglutide featuring a no-extension design, spring-driven mechanism, low consistent force, and ergonomic use with approximately 4 seconds delivery time at max dose.
• ShailyPen Axiom Max GLP-1 pen injector with large dose volume (0.75 ml customizable), zero prime, and low force extension; features dose counter and instruction window for simple user steps.
• ShailyPen Harmony 2 Pen injector available in 3 ml (0.75 ml dose) and 1.5 ml (0.375 ml or 0.1875 ml doses) configurations with low dial extension, dose markings, and audible clicking feedback.
• ShailyPen Maxim 80-unit reusable or disposable pen injector for insulin, GLP-1, and alternate therapies with low extension design, high dose volumes (0.8 ml), and optional resettable functionality.
• Shaily AI Tristan Three-step auto-injector for tirzepatide, dulaglutide, and GLP-1 with automated needle extension and retraction, button lock-out after dosing, approximately 2 second delivery time, and ISO 11040/11608 compliance.
• Shaily AI Toby Two-step auto-injector for GLP-1 and epinephrine available in 1 ml, 2.25 ml, and emergency use configurations with needle cover lock-out after dosing.
• Shaily Mira Wearable auto-injector for various therapies with electronic button actuation, up to 20 ml dose capacity, customizable delivery time (1 minute to 2 hours), and play/pause injection control with LED feedback.
• ShailySafe LAN Safety device for lanreotide with automated needle retraction, device lockout after dosing, suitability for high-viscosity medications, and 20 second delivery time.
• Primary & Specialty Pharmaceutical Packaging High quality packaging for solid orals and liquid formulations including bottles and child-resistant closures (CRCs); specialized packaging for therapies where primary pack aids in delivery; backed by US DMF and Canadian DMF filings.
• CDMO Drug Delivery Contract Manufacturing Contract development and manufacturing organization (CDMO) services for global pharmaceutical companies including design, development, and manufacturing of specialty devices, inhalers, sprays, pumps, insulin injector pens, and auto-injectors.
• Injection Molding & Precision Manufacturing Services Precision injection molding services with 210 machines ranging from 35 to 1200 tons; capable of manufacturing components as small as 0.03 grams with 5 micron tolerances; includes mold manufacturing, secondary operations, and assembly services.
• Sheet Steel Furniture Manufacturing Sheet metal furniture manufacturing producing cabinets, drawer units, tables and storage units for global customers from a 70,000 sq ft plant processing 6,000 tons of steel per annum.

Quantifiable outcome

• Return on Capital Employed (ROCE) of 29%, significantly outperforming Machinery industry average of 15%
• +4 more outcomes

Named customers19 records

Segments4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Two partnerships are on record, tiered core.

• Orbicular Pharmaceutical TechnologiescoreStrategic or Co-development Partner · 21 May 2026Strategic partnership where Orbicular Pharmaceutical Technologies, in partnership with their customer, launched a generic semaglutide injection in Canada using Shaily's proprietary ShailyPen Neo spring-driven pen injector platform. The combination product received USFDA Tentative Approval, Health Canada Notice of Compliance, and India CDSCO approval, and has been commercially available in India since March 2026.
• Undisclosed Domestic Pharmaceutical CompanycoreStrategic or Co-development Partner · 26 February 2026Manufacturing and commercial supply agreement worth approximately ₹423 crore over four years for pen injectors. Customer name not disclosed due to confidentiality. Contract does not involve related party transactions.

Scale indicators17 records

Recent moves3 records

Expansion highlights5 records

Direct peers

• Nemera: French drug delivery device manufacturer producing pen injectors, auto-injectors, inhalers, and patch injectors. Competes with Shaily's ShailyPen Neo and Shaily AI platforms for pharma OEM contracts across injectable therapies.
• Stevanato Group: Italian-based manufacturer of drug containment solutions, pre-filled syringes, and drug delivery devices including pen injectors. Operates a CDMO model serving global pharma - directly comparable to Shaily's healthcare CDMO and platform device business with primary packaging overlap.
• Owen Mumford: UK-based designer and manufacturer of drug delivery devices including pen injectors (AutoPen, UniSafe) and auto-injectors for diabetes and other therapies. Closely comparable to Shaily's pen injector platforms and serves similar global pharma CDMO customers.
• Ypsomed Holding AG: Swiss-headquartered leader in pen injectors and auto-injectors for insulin, GLP-1, and other injectable therapies. Directly comparable to Shaily's ShailyPen/Shaily AI platform devices serving global pharma customers with proprietary drug-delivery platforms.

Broad incumbents

• Gerresheimer AG: German-headquartered manufacturer of primary pharmaceutical packaging (glass and plastic containers, prefillable syringes) and drug delivery devices. Larger European incumbent with overlapping pharma packaging and device CDMO operations.
• Becton Dickinson (BD): US-listed medical technology giant with a substantial pharmaceutical systems segment producing pre-filled syringes, auto-injectors, and pen injectors. Significantly larger and broader, but directly competes in the same pharma drug-delivery device CDMO space.
• AptarGroup: US-listed global supplier of dispensing systems, drug delivery devices, and active material science solutions for pharma, beauty, and consumer markets. Comparable to Shaily's combined pharma drug delivery plus beauty/personal care packaging businesses.
• West Pharmaceutical Services: US-listed global leader in pharmaceutical elastomers, primary packaging, and drug delivery devices including the SmartDose and Daikyo Crystal Zenith platforms. Larger incumbent serving overlapping pharma customers; broader portfolio but comparable drug-delivery component technology.

Regional players

• EPL Limited (formerly Essel Propack): India-listed global leader in laminated and plastic tubes for oral care, beauty, and pharma applications. Comparable precision plastics manufacturer headquartered in India serving consumer goods and pharma customers - similar multi-vertical injection-molded plastics business model.
• Polyplex Corporation Limited: India-listed manufacturer of polyester (PET) films used in packaging and industrial applications. Comparable Indian-listed precision plastics manufacturer with global export footprint; an independent director (Ranjit Singh) of Shaily previously served as Global COO of Polyplex.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/ShailyEngg
• Facebookfacebook.com/ShailyEngineering
• LinkedInlinkedin.com/company/sepl

Compliance16 records

Revenue estimate

Valuation estimate

Number of profiles

Subsidiaries3 records

Funding overview

Funding rounds4 records

Investors4 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Shaily Engineering Plastics